Journal
TRENDS IN MOLECULAR MEDICINE
Volume 17, Issue 2, Pages 78-87Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2010.10.002
Keywords
-
Funding
- NIMH NIH HHS [R01 MH084315, R01 MH084315-10] Funding Source: Medline
Ask authors/readers for more resources
Tuberous sclerosis (TSC) is a genetic disorder caused by heterozygous mutations in the TSC1 or TSC2 genes and is associated with autism spectrum disorders (ASD) in 20-60% of cases. In addition, altered TSC/mTOR signaling is emerging as a feature common to a subset of ASD. Recent findings, in animal models, show that restoration of the underlying molecular defect can improve neurological dysfunction in several of these models, even if treatment is initiated in adult animals, suggesting that pathophysiological processes in the mature brain contribute significantly to the overall neurological phenotype in these models. These findings suggest that windows for therapeutic intervention in ASD could be wider than thought previously.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available